Clinical Trial Update: A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate whether Survodutide (BI 456906) affects the blood levels of bupropion, caffeine, and midazolam in adults with overweight or obesity; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Survodutide (BI 456906) (survodutide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED